U.S. Stocks in Motion | Pharmaceutical Stocks Extend Gains; AstraZeneca (AZN.US) Rises Over 6% After Earnings

Zhitong Finance APP has learned that on Friday, U.S. pharmaceutical stocks continued to rise, with Eli Lilly (LLY.US) up more than 4%, and AstraZeneca (AZN.US) opening sharply higher with a gap up, rising more than 6% as of press time, with a cumulative gain of more than 15% in October. On the news front, AstraZeneca released its third-quarter 2026 results. At constant exchange rates (CER), total revenue for the quarter increased 7% year-on-year to $16.209 billion, product sales were $15.066 billion, up 5%, and alliance revenue was $1.107 billion, up 36%. Core earnings per share were $2.79, up 19% year-on-year; reported earnings per share were $2.02, up 26%. According to expectations compiled by MarketBeat, the market had originally expected core earnings per share of $2.60 and revenue of $16.00 billion for the quarter, and the actual figures were about 7% and 1% higher, respectively.